Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses.

Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses. J Manag Care Spec Pharm. 2020 Jul; 26(7):879-886.

View in: PubMed

subject areas

Adult
Antiviral Agents
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Female
Health Care Costs
Hepatitis C, Chronic
Humans
Male
Markov Chains
Middle Aged

authors with profiles

Bryan L Love